A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]

NCT01022424 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease

Interventions

DRUG: OPC-41061

Sponsor

Otsuka Pharmaceutical Co., Ltd.